Posted in | News | Materials Processing

Potash Corp Announce $73m Expansion to Phosphoric Acid Plant

Potash Corporation of Saskatchewan Inc. (PotashCorp) today announced an 82,000 tonne expansion of its purified phosphoric acid plant at Aurora, North Carolina. The $73.0 million expansion will increase the company's total annual purified acid capacity to 327,000 tonnes and is expected to be fully operational by the second quarter of 2006.

This expansion will not increase the company's overall capacity in phosphoric acid (P(2)O(5)), which is the key ingredient in purified acid. Rather, PotashCorp will be redirecting its existing P(2)O(5) capacity to higher-margin products sold to industrial customers in North America. Historically, these products have provided a significantly higher gross margin than phosphate fertilizers. This expansion will accommodate growing demand in both North and South America.

With this expansion, PotashCorp will continue to capitalize on its competitive advantages in purified phosphoric acid production. Foremost of these is the company's access to high-quality rock in North Carolina with fewer impurities, resulting in superior product quality. The close proximity of this ore body to the Aurora processing facility and the vertical integration of the Aurora phosphate complex also bring inherent cost savings to the process. When the expansion is complete, the plant -- already the world's largest and lowest-cost producer -- will be even larger and more efficient.

"This investment furthers our decommoditization strategy for our phosphate business into higher-margin products," stated Bill Doyle, President and CEO. "We have a defined and distinct advantage in this area and with our advanced production technology and 15 years of operating experience, we believe we can bring further value to our customers."

For more information on phosphoric acid, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.